SEC APPROVAL
Bharat Biotech's Covaxin gets Subject Expert Committee (SEC) approval for emergency use02 Jan, 2021, 07.41 PM IST
Covaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs12 Oct, 2021, 01.50 PM IST
US SEC denies bitcoin ETF has been approved, says account on X was hacked10 Jan, 2024, 07.45 AM IST
- Load More